NCT06795074View on ClinicalTrials.gov

Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

February 28, 2029

Study Completion Date

February 28, 2031

Conditions
Urethral Stricture
Interventions
COMBINATION_PRODUCT

Optilume

Dilatation with drug-coated balloon

DEVICE

UroMax Ultra

Dilatation with non-coated balloon

Trial Locations (4)

Unknown

Sahlgrenska University Hospital, Gothenburg

Skåne University Hospital, Malmo

Örebro University Hospital, Örebro

Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Region Skåne

UNKNOWN

collaborator

Region Stockholm

OTHER_GOV

collaborator

Region Örebro

UNKNOWN

lead

Vastra Gotaland Region

OTHER_GOV